Spero Therapeutics corrects 8-K: charter amendment was not approved; files Certificate of Correction

Spero Therapeutics, Inc.

Amendment No. 1 to 8-K discloses tabulation error in October 5 annual meeting vote.
Charter amendment proposals (officer exculpation, federal forum clause) did not receive required votes.
Certificate of Correction filed Oct 16, 2023 to undo previously recorded charter amendment.
Company states charter remains unchanged as a result of the correction.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Spero Therapeutics, Inc.: Filed a Certificate of Correction to undo the previously filed Charter Amendment due to a tabulation error, restoring the charter to its prior state (effective 2023-10-16).

Change: charter amendment
Effective: 2023-10-16

Exact text from the filing

On October 16, 2023, the Company filed the Certificate of Correction with the Delaware Secretary to undo the Charter Amendment.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

Spero Therapeutics, Inc. shareholders rejected Amend the Charter to reflect new Delaware law provisions regarding officer exculpation and to add a federal forum selection clause.

Proposal: charter amendment
Outcome: failed

Exact text from the filing

The Charter Amendment Proposals did not receive the necessary stockholder votes and were not approved.

View on SEC.gov

Browse all governance changes →

Spero Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-256865

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.